459 related articles for article (PubMed ID: 26088723)
1. Associations of hippocampal metabolism and regional brain grey matter in neuroleptic-naïve ultra-high-risk subjects and first-episode schizophrenia.
Nenadic I; Maitra R; Basu S; Dietzek M; Schönfeld N; Lorenz C; Gussew A; Amminger GP; McGorry P; Reichenbach JR; Sauer H; Gaser C; Smesny S
Eur Neuropsychopharmacol; 2015 Oct; 25(10):1661-8. PubMed ID: 26088723
[TBL] [Abstract][Full Text] [Related]
2. Brain structure in people at ultra-high risk of psychosis, patients with first-episode schizophrenia, and healthy controls: a VBM study.
Nenadic I; Dietzek M; Schönfeld N; Lorenz C; Gussew A; Reichenbach JR; Sauer H; Gaser C; Smesny S
Schizophr Res; 2015 Feb; 161(2-3):169-76. PubMed ID: 25497442
[TBL] [Abstract][Full Text] [Related]
3. Hippocampal metabolism and prefrontal brain structure: A combined 1H-MR spectroscopy, neuropsychological, and voxel-based morphometry (VBM) study.
Steinke J; Gaser C; Langbein K; Dietzek M; Gussew A; Reichenbach JR; Smesny S; Sauer H; Nenadić I
Brain Res; 2017 Dec; 1677():14-19. PubMed ID: 28899759
[TBL] [Abstract][Full Text] [Related]
4. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
[TBL] [Abstract][Full Text] [Related]
5. Glutamatergic dysfunction linked to energy and membrane lipid metabolism in frontal and anterior cingulate cortices of never treated first-episode schizophrenia patients.
Smesny S; Gussew A; Biesel NJ; Schack S; Walther M; Rzanny R; Milleit B; Gaser C; Sobanski T; Schultz CC; Amminger P; Hipler UC; Sauer H; Reichenbach JR
Schizophr Res; 2015 Oct; 168(1-2):322-9. PubMed ID: 26255566
[TBL] [Abstract][Full Text] [Related]
6. Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia.
Natsubori T; Inoue H; Abe O; Takano Y; Iwashiro N; Aoki Y; Koike S; Yahata N; Katsura M; Gonoi W; Sasaki H; Takao H; Kasai K; Yamasue H
Schizophr Bull; 2014 Sep; 40(5):1128-39. PubMed ID: 24023251
[TBL] [Abstract][Full Text] [Related]
7. Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy.
Tandon N; Bolo NR; Sanghavi K; Mathew IT; Francis AN; Stanley JA; Keshavan MS
Schizophr Res; 2013 Aug; 148(1-3):59-66. PubMed ID: 23791389
[TBL] [Abstract][Full Text] [Related]
8. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
[TBL] [Abstract][Full Text] [Related]
9. Cortico-Striatal GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for Psychosis Investigated with Proton Magnetic Resonance Spectroscopy.
de la Fuente-Sandoval C; Reyes-Madrigal F; Mao X; León-Ortiz P; Rodríguez-Mayoral O; Solís-Vivanco R; Favila R; Graff-Guerrero A; Shungu DC
Int J Neuropsychopharmacol; 2015 Sep; 19(3):pyv105. PubMed ID: 26364273
[TBL] [Abstract][Full Text] [Related]
10. Proton magnetic resonance spectroscopy in first episode psychosis and ultra high-risk individuals.
Wood SJ; Berger G; Velakoulis D; Phillips LJ; McGorry PD; Yung AR; Desmond P; Pantelis C
Schizophr Bull; 2003; 29(4):831-43. PubMed ID: 14989417
[TBL] [Abstract][Full Text] [Related]
11. Gray matter abnormalities in subjects at ultra-high risk for schizophrenia and first-episode schizophrenic patients compared to healthy controls.
Witthaus H; Kaufmann C; Bohner G; Ozgürdal S; Gudlowski Y; Gallinat J; Ruhrmann S; Brüne M; Heinz A; Klingebiel R; Juckel G
Psychiatry Res; 2009 Sep; 173(3):163-9. PubMed ID: 19616415
[TBL] [Abstract][Full Text] [Related]
12. Detection of metabolites in the white matter of frontal lobes and hippocampus with proton in first-episode treatment-naïve schizophrenia patients.
He ZL; Deng W; Li ML; Chen ZF; Collier DA; Ma X; Li T
Early Interv Psychiatry; 2012 May; 6(2):166-75. PubMed ID: 21951785
[TBL] [Abstract][Full Text] [Related]
13. Evidence for regional hippocampal damage in patients with schizophrenia.
Singh S; Khushu S; Kumar P; Goyal S; Bhatia T; Deshpande SN
Neuroradiology; 2018 Feb; 60(2):199-205. PubMed ID: 29230507
[TBL] [Abstract][Full Text] [Related]
14. Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis.
de la Fuente-Sandoval C; León-Ortiz P; Favila R; Stephano S; Mamo D; Ramírez-Bermúdez J; Graff-Guerrero A
Neuropsychopharmacology; 2011 Aug; 36(9):1781-91. PubMed ID: 21508933
[TBL] [Abstract][Full Text] [Related]
15. Prefrontal glutamate levels differentiate early phase schizophrenia and methamphetamine addiction: a (1)H MRS study at 3Tesla.
Crocker CE; Bernier DC; Hanstock CC; Lakusta B; Purdon SE; Seres P; Tibbo PG
Schizophr Res; 2014 Aug; 157(1-3):231-7. PubMed ID: 24906219
[TBL] [Abstract][Full Text] [Related]
16. Hippocampal pathology in individuals at ultra-high risk for psychosis: a multi-modal magnetic resonance study.
Wood SJ; Kennedy D; Phillips LJ; Seal ML; Yücel M; Nelson B; Yung AR; Jackson G; McGorry PD; Velakoulis D; Pantelis C
Neuroimage; 2010 Aug; 52(1):62-8. PubMed ID: 20399273
[TBL] [Abstract][Full Text] [Related]
17. Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging.
Bertolino A; Kumra S; Callicott JH; Mattay VS; Lestz RM; Jacobsen L; Barnett IS; Duyn JH; Frank JA; Rapoport JL; Weinberger DR
Am J Psychiatry; 1998 Oct; 155(10):1376-83. PubMed ID: 9766769
[TBL] [Abstract][Full Text] [Related]
18. Prediction of functional outcome 18 months after a first psychotic episode: a proton magnetic resonance spectroscopy study.
Wood SJ; Berger GE; Lambert M; Conus P; Velakoulis D; Stuart GW; Desmond P; McGorry PD; Pantelis C
Arch Gen Psychiatry; 2006 Sep; 63(9):969-76. PubMed ID: 16952999
[TBL] [Abstract][Full Text] [Related]
19. Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction.
Plitman E; de la Fuente-Sandoval C; Reyes-Madrigal F; Chavez S; Gómez-Cruz G; León-Ortiz P; Graff-Guerrero A
Schizophr Bull; 2016 Mar; 42(2):415-24. PubMed ID: 26320195
[TBL] [Abstract][Full Text] [Related]
20. [Proton magnetic resonance spectroscopy and diffusion tensor imaging study of first-episode patients with positive symptoms of schizophrenia].
Jia YB; Wang Y; Ling XY; Zhong SM; Huang L
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):374-8. PubMed ID: 22445987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
